Stephan Fritschi

Carbogen Amcis has appointed Stephan Fritschi as CEO

Carbogen Amcis has appointed Stephan Fritschi, who is currently serving as the company’s Chief Alliance Officer and Deputy CEO, as Chief Executive Officer (CEO).

Fritschi will take on his new role at the pharmaceutical process development and active pharmaceutical ingredient manufacturing company in April, following the departure of current CEO Pascal Villemagne.

He has held roles of increasing responsibility during more than 25 years at Carbogen Amcis, more recently serving as Executive Vice President, Business Units and Executive Vice President, Operations.

Christian Eich, Chairman of Carbogen Amcis, said: “With more than 25 years at Carbogen Amcis, a perfect knowledge of the company and extensive experience in the pharmaceutical market, Stephan Fritschi brings a deep understanding of the company’s operations, values and strategic direction, [assuring] continuity in growing the business.”

Commenting on his latest venture, Fritschi said: “I am honoured to take on this role and lead Carbogen Amcis into the future. I look forward to collaborating with the team to continue the progress we have made and to build on the foundations laid by my predecessor, ensuring we continue to deliver value to our customers, employees and stakeholders.”